The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Central role for GSK3β in the pathogenesis of arrhythmogenic cardiomyopathy
Open accessAbstract
Arrhythmogenic cardiomyopathy (ACM) is characterized by redistribution of junctional proteins, arrhythmias, and progressive myocardial injury. We previously reported that SB216763 (SB2), annotated as a GSK3β inhibitor, reverses disease phenotypes in a zebrafish model of ACM. Here, we show that SB2 prevents myocyte injury and cardiac dysfunction in vivo in two murine models of ACM at baseline and in response to exercise. SB2-treated mice with desmosome mutations showed improvements in ventricular ectopy and myocardial fibrosis/inflammation as compared with vehicle-treated (Veh-treated) mice. GSK3β inhibition improved left ventricle function and survival in sedentary and exercised Dsg2 mut/mut mice compared with Veh-treated Dsg2 mut/mut mice and normalized intercalated disc (ID) protein distribution in both mutant mice. GSK3β showed diffuse cytoplasmic localization in control myocytes but ID redistribution in ACM mice. Identical GSK3β redistribution is present in ACM patient myocardium but not in normal hearts or other cardiomyopathies. SB2 reduced total GSK3β protein levels but not phosphorylated Ser 9–GSK3β in ACM mice. Constitutively active GSK3β worsens ACM in mutant mice, while GSK3β shRNA silencing in ACM cardiomyocytes prevents abnormal ID protein distribution. These results highlight a central role for GSKβ in the complex phenotype of ACM and provide further evidence that pharmacologic GSKβ inhibition improves cardiomyopathies due to desmosome mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This model exhibits progressive myocardial inflammation, fibrotic remodeling, and ventricular dysfunction and arrhythmias.”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [60]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“findings from this model demonstrate that myocardial inflammation arises intrinsically (i.e., from cardiomyocytes) due to the presence of a desmosomal mutation, rather than solely from infiltrative immune cells, supporting the concept that inflammation is a primary driver of disease progression and an emerging therapeutic target in ACM.”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [60]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Uniquely, GSK3β localization at the intercalated disc (ID) was observed in ACM hearts. This finding was in stark contrast to other inflammatory heart diseases, such as giant cell myocarditis and cardiac sarcoidosis, where GSK3β localization was predominantly cytoplasmic [60].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [60]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Aberrant GSK3β activity in ACM is also linked to the deleterious activation of NFκB [11,12,60].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [60]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Together, the suppression of Wnt and overactivation of NFκB drive pro-inflammatory, adipogenic, and fibrotic gene expression programs [60].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [60]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pharmacological inhibition of GSK3β (e.g., SB216763) prevented myocyte injury and cardiac dysfunction in two murine models of ACM (Dsg2mut/mut and JUP2157del2) at rest and in response to exercise, where SB216763-treated mice demonstrated improvements in ventricular ectopy and function, myocardial fibrosis and inflammation, and normalization of ID proteins, and, most importantly, increased survival”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [60]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The germline Dsg2mut/mut mouse model developed by Chelko SP and colleagues represents a more genetically relevant system for studying ACM pathogenesis, as the Dsg2 mutation is germline, mirroring the pattern of inheritance observed in patients [12,60].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [60]
The cited source says what the claim attributes to it.
In the citing paper
“uniquely distinguishing features have been noted in ACM hearts, such as loss of junctional plakoglobin (JUP), Cx43 [73], and SAP97 [74] at the ID, in conjunction with GSK3β redistribution to the ID [60], demonstrating that desmosomal disruption imparts uniquely specific pathological characteristics in ACM.”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [60]
The cited source says what the claim attributes to it.
In the citing paper
“Dysregulation of GSK3β, involved in the suppression of the Wnt/β-catenin pathway, has also been implicated in ACM pathogenesis, particularly in the promotion of fibrosis and inflammation, and is effectively inhibited by SB216763 in preclinical ACM models [60,74,116,117].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [60]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In Dsg2mut/mut mice, myocardial levels of IL-1β, IFN-γ, IL-12, LIX (CXCL5), and Osteopontin (OPN) are substantially elevated.”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [60]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Multiple pro-inflammatory cytokines and chemokines have been shown to be upregulated early in ACM pathogenesis.”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [60]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Notably, LIX and OPN levels show a significant inverse correlation with cardiac function and a positive correlation with myocardial fibrosis [60]”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [60]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Engineering cell shape and function
Singhvi, R., Kumar, A., Lopez, G. P., Stephanopoulos, G. N., Wang, D. I. C., Whitesides, G. M., & Ingber, D. E. (1994) · Science · doi:10.1126/science.8171320 · Cited by 1,453
Coghlan, M. P., Culbert, A. A., Cross, D. A. E., Corcoran, S. L., Yates, J. W., Pearce, N. J., Rausch, O., Murphy, G. J., Carter, P. S., Cox, L. R., et al. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00025-9 · Cited by 906
Wnt Signaling through Inhibition of β-Catenin Degradation in an Intact Axin1 Complex
Li, V. S. W., Ng, S. S., Boersema, P. J., Low, T. Y., Karthaus, W. R., Gerlach, J. P., Mohammed, S., Heck, A. J. R., Maurice, M. M., Mahmoudi, T., et al. (2012) · Cell · doi:10.1016/j.cell.2012.05.002 · Cited by 889 · cited 1×
“The cytosolic Axin-APC-GSK3β complex targets β-catenin for degradation via phosphorylation of Ser/Thr residues, first by the priming kinase, casein kinase-1 at Ser45, and subsequently by GSK3β at Ser33/37/Thr41 (15), and SB2 is annotated as an inhibitor of GSK3β (4, 5).”
James, C. A., Bhonsale, A., Tichnell, C., Murray, B., Russell, S. D., Tandri, H., Tedford, R. J., Judge, D. P., & Calkins, H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.06.033 · Cited by 710
Self-citationHigh-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart
Andrassy, M., Volz, H. C., Igwe, J. C., Funke, B., Eichberger, S. N., Kaya, Z., Buss, S. J., Autschbach, F., Pleger, S. T., Lukić, I. K., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.769331 · Cited by 635
Garcia-Gras, E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27751 · Cited by 623
Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis
McManus, E. J., Sakamoto, K., Armit, L. J., Ronaldson, L., Shpiro, N., Marquez, R., & Alessi, D. R. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600633 · Cited by 594
A New Diagnostic Test for Arrhythmogenic Right Ventricular Cardiomyopathy
Asimaki, A., Tandri, H., Huang, H., Halushka, M. K., Gautam, S., Basso, C., Thiene, G., Tsatsopoulou, A., Protonotarios, N., McKenna, W. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808138 · Cited by 456
Self-citationKirchhof, P., Fabritz, L., Zwiener, M., Witt, H., Schäfers, M., Zellerhoff, S., Paul, M., Athai, T., Hiller, K.-H., Baba, H. A., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.624502 · Cited by 429
Cited by
Sorted by citations
Items 101–182 of 182
Determinants of electrical propagation and propagation block in Arrhythmogenic Cardiomyopathy
Jin, Q., Lee, K. Y., Selimi, Z., Shimura, D., Wang, E. B., Zimmerman, J. F., Shaw, R. M., Kučera, J., Parker, K. K., Saffitz, J. E., et al. (2023) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2023.11.003 · Cited by 13
Self-citationHistopathological Features and Protein Markers of Arrhythmogenic Cardiomyopathy
Bueno-Beti, C., & Asimaki, A. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.746321 · Cited by 12
Self-citationInterleukin-1β Drives Disease Progression in Arrhythmogenic Cardiomyopathy
Penna, V. R., Amrute, J., Engel, M., Shiel, E. A., Farra, W., Cannon, E. N., Leu-Turner, C., Ma, P., Villanueva, A., Shin, H.-W., et al. (2026) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2026.101542 · Cited by 12
Self-citationBeffagna, G., Sommariva, E., & Bellin, M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.568535 · Cited by 11
Peretto, G., Villatore, A., & Cooper, L. T. (2026) · Immunological Reviews · doi:10.1111/imr.70105 · Cited by 10
Marchal, G. A., Galjart, N., Portero, V., & Remme, C. A. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad052 · Cited by 10
Disease modeling of cardiac arrhythmias using human induced pluripotent stem cells
Liang, W., Gasparyan, L., Alqarawi, W., & Davis, D. R. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1575359 · Cited by 9
Cheedipudi, S. M., Fan, S., Rouhi, L., & Marian, A. J. (2021) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2021.04 · Cited by 9
Centner, A. M., Shiel, E. A., Farra, W., Cannon, E. N., Landim-Vieira, M., Salazar, G., & Chelko, S. P. (2024) · Nutrients · doi:10.3390/nu16132087 · Cited by 8
Self-citationThe Challenges of Diagnosis and Treatment of Arrhythmogenic Cardiomyopathy: Are We there yet?
Spadotto, A., Morabito, D., Carecci, A., Massaro, G., Statuto, G., Angeletti, A., Graziosi, M., Biagini, E., Martignani, C., Ziacchi, M., et al. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2308283 · Cited by 8
Targeting arrhythmogenic macrophages: lessons learned from arrhythmogenic cardiomyopathy
Mesquita, T., & Cingolani, E. (2024) · Journal of Clinical Investigation · doi:10.1172/jci180482 · Cited by 8
Molecular mechanisms in the pathogenesis of arrhythmogenic cardiomyopathy
Saffitz, J. E. (2017) · Cardiovascular Pathology · doi:10.1016/j.carpath.2017.02.005 · Cited by 8
Self-citationProtonotarios, A., & Elliot, P. M. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.06.117 · Cited by 8
Landim-Vieira, M., Kahmini, A. R., Engel, M., Cannon, E. N., Amat-Alarcon, N., Judge, D. P., Pinto, J. R., & Chelko, S. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213909 · Cited by 7
Self-citationExercise in Inherited Cardiomyopathies: Optimizing the Dose-Response Curve
Rye, E. E., Mitchell, A. M., Santiago, C. F., Gerche, A. L., & Fatkin, D. (2025) · Circulation Research · doi:10.1161/circresaha.125.326396 · Cited by 7
Vencato, S., Romanato, C., Rampazzo, A., & Calore, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116208 · Cited by 7
Panigrahy, D., Kelly, A. G., Quinlivan, K. M., Wang, W., Yang, J., Hwang, S. H., Gillespie, M., Howard, I. V., Bueno‐Betí, C., Asimaki, A., et al. (2025) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2024.12.010 · Cited by 7
Self-citationFabritz, L., Fortmueller, L., Gehmlich, K., Kant, S., Kemper, M., Kucerova, D., Syeda, F., Faber, C., Leube, R. E., Kirchhof, P. F., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12050985 · Cited by 6
Arrhythmogenic Cardiomyopathy: Current Updates and Future Challenges
Zathar, Z., Shah, N., Desai, N., & Patel, P. A. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2506208 · Cited by 6
GSK3-inhibition improves maximal SERCA activity in a murine model of Arrhythmogenic cardiomyopathy
Hamstra, S. I., Braun, J. L., Chelko, S. P., & Fajardo, V. A. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166536 · Cited by 6
Self-citationNo major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathy
Hoorntje, E. T., Pósafalvi, A., Syrris, P., van der Velde, K. J., Bolling, M. C., Protonotarios, A., Boven, L. G., Amat-Codina, N., Groeneweg, J. A., Wilde, A. A. M., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203078 · Cited by 6
Self-citationAnalysis of buccal mucosa as a prognostic tool in children with arrhythmogenic cardiomyopathy
Bueno‐Betí, C., Field, E., Tsatsopoulou, A., Perry, G., Sheppard, M. N., Behr, E. R., Saffitz, J. E., Kaski, J. P., & Asimaki, A. (2021) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2021.101458 · Cited by 7
Self-citationBasso, C., Zaglia, T., & Pilichou, K. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab512 · Cited by 6
Low, B. S. H., & Asimaki, A. (2024) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-024-10567-x · Cited by 5
Self-citationNew Insights Into Genetic Right Ventricular Cardiomyopathies
Garcia-Montero, M., Fanous, Y., Krahn, A. D., Davies, B., Cadrin‐Tourigny, J., & Roberts, J. D. (2025) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2025.02.020 · Cited by 5
Malhotra, N., Cavus, O., Wallace, M. J., Bobik, J. T., You, K., Takenaka, S. S., Abdallah, D., Mohler, E. J., Antwi-Boasiako, S., Murphy, N. P., et al. (2025) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2025.03.013 · Cited by 5
Self-citationShiel, E. A., Farra, W., Medarev, S. L., Ariyaratne, G. H. D. N., Cannon, E. N., Steiner, J. L., & Chelko, S. P. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00416.2025 · Cited by 5
Self-citationIn Vivo Approaches to Understand Arrhythmogenic Cardiomyopathy: Perspectives on Animal Models
Risato, G., Casas, R. B., Cason, M., Marinas, M. B., Pinci, S., Gaspari, M. D., Visentin, S., Rizzo, S., Thiene, G., Basso, C., et al. (2024) · Cells · doi:10.3390/cells13151264 · Cited by 4
Molecular Pathogenesis of Arrhythmogenic Cardiomyopathy: Mechanisms and Therapeutic Perspectives
Popa, E., & Hostiuc, S. (2025) · Biomolecules · doi:10.3390/biom15111512 · Cited by 4
Jürgens, K., Menzel, L., Klinke, N., Schäper, L., Breitsprecher, L. F., Holtmannspötter, M., Psathaki, O. E., Walter, S., Ratnavadivel, S., Malmendal, A., et al. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05942-z · Cited by 4
Circulation and Contacts in Sixteenth Century New Cartography: Spain, Portugal and Italy
Madrid, J. M. M. (2021) · Culture & History Digital Journal · doi:10.3989/chdj.2021.015 · Cited by 4
Yeh, Y.-H., Ko, Y.-S., Chan, Y.-H., Lai, Y.-J., Chang, G.-J., Chang, C.-J., & Hsu, L.-A. (2026) · Circulation: Genomic and Precision Medicine · doi:10.1161/circgen.125.005434 · Cited by 3
Elucidating arrhythmogenic right ventricular cardiomyopathy with stem cells
Laurita, K. R., Vasireddi, S. K., & Mackall, J. A. (2022) · Birth Defects Research · doi:10.1002/bdr2.2010 · Cited by 3
Emerging Targeted Therapies for Inherited Cardiomyopathies and Arrhythmias
Ryan, T. L., & Roberts, J. D. (2023) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2023.04.006 · Cited by 3
Inherited Ventricular Arrhythmia in Zebrafish: Genetic Models and Phenotyping Tools
Sieliwończyk, E., Matchkov, V. V., Vandendriessche, B., Alaerts, M., Bakkers, J., Loeys, B., & Schepers, D. (2021) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2021_65 · Cited by 3
A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease
Ariyaratne, G. H. D. N., Villatore, A., Peretto, G., & Chelko, S. P. (2026) · Cells · doi:10.3390/cells15100868 · Cited by 2
Self-citationNoort, R. J., Salman, W., Fuchs, C., Braun, U., Pace, D., Hodgkinson, K. A., & Esseltine, J. L. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.01025.2024 · Cited by 2
Multi-Faceted Approach to Ventricular Tachycardia: A Review of Management Strategies
Hartge, F., Skeete, J., Pinedo, A., Zeleke, B., Khan, A., Mekritthikrai, R., & Dye, C. A. (2024) · Pharmacoepidemiology · doi:10.3390/pharma3030018 · Cited by 2
WNT Signaling and Cardiac Fibrosis
Lluri, G., & Deb, A. (2018) · Molecular and translational medicine · doi:10.1007/978-3-319-98143-7_11 · Cited by 2
Maniar, Y. M., Gilotra, N. A., & Scheel, P. J. (2023) · Biomedicines · doi:10.3390/biomedicines11123259 · Cited by 2
Asimaki, A. (2020) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2020.07.007 · Cited by 2
Self-citationGabrielson, K. L., Behera, A., Sysa‐Shah, P., Creamer, T. J., & Cooper, T. K. (2021) · Wiley eBooks · doi:10.1002/9781119624608.ch14 · Cited by 2
Вайханская, Т. Г. (2025) · Кардиология в Беларуси · doi:10.34883/pi.2025.17.6.008 · Cited by 1
Desmoglein-2 deficiency drives mitochondrial morphological remodeling in cardiomyocytes
Gonçalves, A., Chen, E. Z., Rastegarpouyani, H., Fernandes, A. A., Alves, I. N., Sequeira, V., Kwon, C., Chelko, S. P., & Landim-Vieira, M. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00368.2026 · Cited by 1
Self-citationNavigating the Complexity: A Comprehensive Review of GSK‐3 Inhibition in Regenerative Medicine
Schiroli, D., Merra, A., Marraccini, C., Merolle, L., Pellegrini, G., & Maurizi, E. (2026) · Medicinal Research Reviews · doi:10.1002/med.70095 · Cited by 1
Pathogenesis, Diagnosis and Risk Stratification in Arrhythmogenic Cardiomyopathy
Florio, M. T., Boccia, F., Vetrano, E., Borrelli, M., Gossios, T. D., & Palmiero, G. (2021) · Cardiogenetics · doi:10.3390/cardiogenetics11040025 · Cited by 1
Шестак, А. Г., Blagova, O. V., Lutokhina, Y. A., Sl, D., & Zaklyazminskaya, E. V. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4692 · Cited by 1
Heart Failure in Arrhythmogenic Cardiomyopathy: Is Phenotypic Variability Just a Matter of Genetics?
Pilichou, K., & Basso, C. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1456 · Cited by 1
Cirnu, A., Williams, T., Noerpel, M., Kammerer, J., Kannt, S., Heil, M., Kimmel, L., Arias-Loza, P.-A., Lhoda, M., Hennig, T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.11.693827 · Cited by 1
Deo, R. C. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2016.05.009
Heart Failure as a Consequence of Genetic Cardiomyopathy
Judge, D. P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-60987-6.00024-7
Self-citationA clinical case of arrhythmogenic right ventricular dysplasia
Solovyoval, E. V., Попова, Н. А., Vlasoval, T. V., Gorbunova, M., & Antsygina, L. N. (2021) · South Russian Journal of Therapeutic Practice · doi:10.21886/2712-8156-2021-2-1-109-114
Role of galectin-3 in the pathogenesis of arrhythmogenic cardiomyopathy—It’s complicated
Chelko, S. P., & Saffitz, J. E. (2021) · Heart Rhythm · doi:10.1016/j.hrthm.2021.04.022
Self-citationNew Insights Into the Role of GSK-3 in the Regulation of Human Cardiac Electrophysiology
Forte, M., Iacovone, G., & Sciarretta, S. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.06.011
Parsing cell death in arrhythmogenic cardiomyopathy: PANoptosis
MacRae, C. A. (2023) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2022.45
Self-citationCheek-Pro-Heart: What Can the Buccal Mucosa Do for Arrhythmogenic Cardiomyopathy?
Bueno‐Betí, C., & Asimaki, A. (2023) · Biomedicines · doi:10.3390/biomedicines11041207
Self-citationMolecular Pathways and Animal Models of Arrhythmias
Stevens, T. L., Coles, S. A., Sturm, A. C., Hoover, C. A., Borzok, M. A., Mohler, P. J., & Refaey, M. E. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-44087-8_67
Bona, A. D., Guazzo, A., Vanaja, I. P., Bariani, R., DISALVO, M. C., Albiero, M., Kuperwasser, N., David, P., Celeghin, R., Mauro, V. D., et al. (2025) · medRxiv · doi:10.1101/2025.01.14.24319713
Li, W., Wang, M., Ruan, Z., Ren, Y., Zhu, L., & Zhang, B. (2025) · Biochemical Genetics · doi:10.1007/s10528-025-11052-z
Hanns, P., Colpaert, R. M. W., Castellanos-Martínez, R., Weidner, F., Beensen, S., Matthias, F., Xu, L., Kuster, G. M., & Schinner, C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.23.643549
Kapoor, A., Chopra, A. K., & Singh, H. (2025) · Cardiology and Cardiovascular Research · doi:10.11648/j.ccr.20250902.14
Towards Mechanism-Based Therapies in Arrhythmogenic Cardiomyopathy
Saffitz, J. E. (2025) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2025.05.008
Self-citationThe blueprint of neurocardiac crosstalk in arrhythmic syndromes
Zaglia, T., Vanaja, I. P., Guazzo, A., & Mongillo, M. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00558.2025
Phenotypic screening for new heart failure therapeutics: scalable animal modeling in zebrafish
MacRae, C. A. (2025) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2025.2552148
Self-citationLandim-Vieira, M., Jani, V., Shiel, E., Rastegarpouyani, H., Engel, M., Cullup, F. P., Chastain, R., Farra, W., Ma, W., Toepfer, C. N., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.03.680335
Self-citationChoi, Y., Son, Y. H., Kim, M. S., Park, S., & Lee, K. Y. (2025) · BioChip Journal · doi:10.1007/s13206-025-00245-8
Emerging Targeted Therapies for Inherited Cardiomyopathies and Arrhythmias
Ryan, T. L., & Roberts, J. D. (2025) · Heart Failure Clinics · doi:10.1016/j.hfc.2025.08.004
Murata, H. (2025) · Circulation Journal · doi:10.1253/circj.cj-25-0908
Fu, M., Hua, X., Shu, S., Xu, X., Zhang, H., Peng, Z., Mo, H., Liu, Y., Chen, X., Yang, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26659372
Fu, M., Hua, X., Shu, S., Xu, X., Zhang, H., Peng, Z., Mo, H., Liu, Y., Chen, X., Yang, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26659366
Fu, M., Hua, X., Shu, S., Xu, X., Zhang, H., Peng, Z., Mo, H., Liu, Y., Chen, X., Yang, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24956003
Fu, M., Hua, X., Shu, S., Xu, X., Zhang, H., Peng, Z., Mo, H., Liu, Y., Chen, X., Yang, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26659369
Fu, M., Hua, X., Shu, S., Xu, X., Zhang, H., Peng, Z., Mo, H., Liu, Y., Chen, X., Yang, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26659375
Fu, M., Hua, X., Shu, S., Xu, X., Zhang, H., Peng, Z., Mo, H., Liu, Y., Chen, X., Yang, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26659378
Fu, M., Hua, X., Shu, S., Xu, X., Zhang, H., Peng, Z., Mo, H., Liu, Y., Chen, X., Yang, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24956203
Blandin, C. (2023) · theses.fr (ABES) · doi:10.70675/bedafc9ez5195z4b52z913bz548743c18b89
Pathak, S., Stangner, K., Kempf, E., Moztarzadeh, S., Hiermaier, M., Wider, S., Rauschmayer, M., Williams, T., Stengl, A., Gerull, B., et al. (2026) · Acta Physiologica · doi:10.1111/apha.70254
A zebrafish stable model of Galectin-3 to elucidate its role in arrhythmogenic cardiomyopathy
Risato, G., Celeghin, R., Cason, M., Marinas, M. B., Pinci, S., Casas, R. B., Gaspari, M. D., Barbera, M. D., Facchinello, N., Rizzo, S., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-56956-x
Minor, K. E., Lee, C. F., & Nizami, H. L. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00633.2026
Simonson, B., Chaffin, M. D., Guedira, Y., Choudhury, T. Z., Xiao, L., Ruan, R., Schneider, K., Morris, J., Koledova, V. V., Bedi, K. C., et al. (2026) · iScience · doi:10.1016/j.isci.2026.117486
Role of Inflammation in Genetically Determined Cardiomyopathies
Merlo, M., Bassetto, G., Perotto, M., Gonano, N., Viotto, L., Guarnaccia, A., Imazio, M., & Sinagra, G. (2026) · Springer eBooks · doi:10.1007/978-3-032-34334-5_10
CD14 Blockade Attenuates Arrhythmogenic CardiomyopathyPreprint
Penna, V. R., Shiel, E. A., Farra, W., Cannon, E. N., Landim-Vieira, M., Owen, M. C., Venkatesan, R., Heo, G. S., Das, A., Liu, Y., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.30.755828
Self-citation
Metadata
- Authors
- Chelko, S. P., Asimaki, A., Andersen, P., Bedja, D., Amat-Alarcon, N., DeMazumder, D., Jasti, R., MacRae, C. A., Leber, R., Kleber, A. G., Saffitz, J. E., & Judge, D. P.
- Affiliations
- Johns Hopkins University (US)
- Beth Israel Deaconess Medical Center (US)
- Department of Medicine/Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Brigham and Women's Hospital (US)
- Schiller AG, Research and Development, Baar, Switzerland.
- Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
- Corresponding author
- Saffitz, Jeffrey E.
- Judge, Daniel P.
- ORCID
- Venue
- JCI Insight
- Published
- 2016-04-21
- Volume
- 1
- Issue
- 5
- ISSN
- 2379-3708 (ISSN-L)
- PMC
- PMC4861310
- OpenAlex
- W2341491381
- Cited by
- 180
- References
- 39
- Citations by year
- 2026: 10 · 2025: 27 · 2024: 16 · 2023: 23 · 2022: 12 · 2021: 30 · 2020: 21 · 2019: 14 · 2018: 12 · 2017: 13 · 2016: 2
- FWCI
- 11.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- JCI Insight (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- University of Miami
- Hartwell Foundation
- National Institutes of Health (R24OD017870)
- Leonard M. Miller School of Medicine
- National Heart, Lung, and Blood Institute (RC1HL100110, K99HL130662, R01HL102361)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- arrhythmogenic cardiomyopathy, GSK3β, SB216763, GSK-3β inhibition, desmoglein 2, ventricular ectopy, myocardial fibrosis, exercise-induced cardiomyopathy, cardiac dysfunction, zebrafish model, mouse model, cardiomyocyte injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
